| Amber Dawn Moore, | |
|
2100 N Summit St, Arkansas City, KS 67005-3855 | |
| (620) 441-0283 | |
| (620) 441-0887 |
| Full Name | Amber Dawn Moore |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2100 N Summit St, Arkansas City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326329574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-13864 (Kansas) | Primary |
| 183500000X | Pharmacist | 13530 (Oklahoma) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber Dawn Moore, 2100 N Summit St, Arkansas City, KS 67005-3855 Ph: (620) 441-0283 | Amber Dawn Moore, 2100 N Summit St, Arkansas City, KS 67005-3855 Ph: (620) 441-0283 |
News Archive
UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.
In a first of its kind study in the U.S., researchers at the Perelman School of Medicine at the University of Pennsylvania have shown that the addition of graphic warning labels on cigarette packaging can improve smokers' recall of the warning and health risks associated with smoking. The new findings are published online-first in the American Journal of Preventive Medicine.
The University of North Carolina at Chapel Hill has received a grant worth nearly $1.6 million over four years from the Agency for Healthcare Research and Quality to help reduce vision problems in African-Americans caused by glaucoma.
CSL Biotherapies welcomed news overnight of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits.
Seattle Genetics Inc's new blood cancer drug Adcetris is will come with a price tag of $100,000 for a course of treatment. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first drug specifically indicated for anaplastic large cell lymphoma (ALCL) and the first one approved for Hodgkin's lymphoma since 1977.
› Verified 9 days ago
Erica Tackett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2701 N Summit St, Arkansas City, KS 67005 Phone: 620-442-2051 | |
Koffi Kolagbe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 N Summit St, Arkansas City, KS 67005 Phone: 620-442-7842 | |
Meagan Mason, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 N Summit St, Arkansas City, KS 67005 Phone: 620-441-0283 Fax: 620-441-0887 | |
Karen Kay Pontius, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 S Summit St, Arkansas City, KS 67005 Phone: 620-442-3500 | |
Heather Lowrie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 S Summit St, Arkansas City, KS 67005 Phone: 620-442-2300 Fax: 620-442-9498 | |
Megan Marie Mangrum, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 N Summit St, Arkansas City, KS 67005 Phone: 620-442-7842 |